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Abstract 
 
 
 Eotaxin is a potent chemoattractant for eosinophils that becomes elevated in the 
tissues in response to inflammation and increased adiposity.   Therefore, eosinophil 
migration into adipose tissue should increase in diet-induced obese individuals, yet it 
does not. This suggested to us that something within the cellular microenvironment of 
diet-induced obese individuals might be altering the endothelial leukocyte adhesion 
molecules (ELAM) such as VCAM-1 or selectins on the endothelial cells, thus 
preventing eosinophils from entering the inflamed tissue. Connexons are gap junctions in 
endothelial cells and on immune cells such as macrophages that are composed of 
connexins and have been shown to alter ELAM expression. In this study, we investigated 
whether connexin 43 expression can be modulated by saturated or unsaturated fatty acids. 
We found that the saturated fatty acids, palmitic and lauric acid, increased expression of 
connexin 43 in bEnd.3 endothelial cells over a 24-hour period at concentrations ranging 
from 100μM to 400μM.  Conversely, linoleic acid, an unsaturated fatty acid, decreased 
the expression of connexin 43 over a 24-hour period at concentrations from 400μM to 
800μM.  Connexins 37 and 40 were also examined but were not detected under the 
conditions used.  These results suggest that the concentration and type of fatty acids in 
the blood can significantly impact connexin expression by vascular endothelial cells and 
the subsequent regulation of adhesion molecule expression necessary for eosinophil 
migration into inflamed tissues. 
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Introduction 
The chronic low-grade inflammation that defines obesity (1) results from a 
dominance of M1 macrophages resident in the adipose tissue.  These macrophages are 
stimulated to produce inflammatory cytokines through the binding of lipopolysaccharide 
or saturated fatty acids (SFA) to the TLR-4 receptors which they express.  Thus, the high 
fat diet of the obese individual continuously favors the differentiation of these tissue 
macrophages to the pro-inflammatory M1 phenotype (1-9).  Inflammatory cytokines and 
diet-induced obesity both result in increased eotaxin secretion (4) by adipocytes and 
immune cells to attract eosinophils to the adipose tissue.  The eosinophils, in turn, would 
produce IL-4 and IL-13 to shift the macrophage differentiation to the anti-inflammatory 
M2 phenotype in order to regain homeostasis.  It has been observed, however, that 
despite the increased eotaxin production in the obese individual, the eosinophil numbers 
are reduced in adipose tissue when high levels of SFA and inflammatory cytokines are 
present. This suggests that the reduced eosinophil numbers in adipose tissue (10, 11) may 
be due to the cells’ inability to migrate across the endothelial barrier into the tissue, quite 
possibly due to alterations in the adhesion molecules expressed in the presence of the 
inflammatory cytokines and SFA (10-14).  
Connexins are gap junction proteins expressed in the vascular endothelium that 
are able to regulate the expression of endothelial cell adhesion molecules. While 
connexins have received considerable attention because of their role in intercellular 
communication and cardiovascular health and disease, more recent studies have revealed 
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their importance in tissue inflammation and repair as well.  There are over 20 
members in the connexin family of proteins.  These proteins are defined by their ability to 
form hemi-channels in the plasma membrane to dock with their counterparts on 
neighboring cells, forming gap junctions for the propagation of electrical signals and the 
diffusion of ions and second messengers. (12-14).   Three connexin family members are 
relevant to the expression of adhesion molecules that are used for leukocyte migration. 
Connexins 40 and 43 are capable of directly altering surface adhesion molecule 
expression, whereas Cx37 is located on smooth muscle cells and on macrophages and 
indirectly influences adhesion molecules expression through the release of ATP onto the 
endothelial cell surface.   
Because vascular endothelial cells express receptors for inflammatory cytokines 
and TLR-4 receptors specific for LPS and SFA, it is possible that the cells respond to 
these ligands by altering connexin expression which in turn modifies adhesion molecule 
expression.   The selectins as well as the integrins, vascular cell adhesion molecule 1 and 
intracellular adhesion molecule 1(VCAM-1 and ICAM-1), are responsive to changes in 
connexins and these adhesion molecules would impact the efficiency of eosinophil 
transmigration across the endothelial barrier (12-14). Previous studies have shown that 
Cx40 increases VCAM-1 and P-selectin expression and, while these molecules are 
necessary for recruitment and initial attachment of the eosinophils to the endothelial 
surface, strong binding would prevent the eosinophils from releasing VCAM-1 at the 
luminal surface for subsequent binding to ICAM-1; ICAM-1 is located on the membrane 
between adjacent cells and is critical for adhesion during transmigration into the inflamed 
adipose tissue.   
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The aim of this study is to determine whether saturated or unsaturated fatty acids 
can alter the expression of connexins on endothelial cells. We would predict that SFA 
binding to the TLR-4 receptor would increase expression of Cx43 while decreasing Cx40 
expression on endothelial cells. This would induce strong expression of P-selectin and 
VCAM-1 on the luminal surface of the endothelial layer and impede the eosinophil 
transmigration.  Conversely, UFA would increase Cx40 expression while decreasing 
Cx43 expression on the endothelial cells. This would be expected to reduce the levels of 
VCAM-1 expression such that eosinophil transmigration across the endothelial barrier 
would be enhanced.  A second goal of this study is to determine whether eosinophils 
express Cx37 or Cx43, as do macrophages and neutrophils. Based on its function in 
macrophages, Cx37 expression by eosinophils would be expected to negatively influence 
surface adhesion molecule expression on the endothelial barrier and thus prevent their 
migration into the inflamed adipose tissue (13, 14).  
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Methods 
 
Materials 
Pre-stained, low molecular weight markers were purchased from BioRad 
(Hercules, CA). Primary antibodies were purchased as follows: Connexin 43 from Sigma 
Aldrich (St. Louis, MO), Connexin 40 from Chemicon (Billerica, MA) and Connexin 37 
from Alpha Diagnostics International Inc. (San Antonio, Texas). Hematoxylin, glass 
slides and cover slips as well as materials for H&E staining were kindly provided by the 
Dermatology Associates of West Michigan. 
 
Cell Culture 
Endothelial cells: bEnd.3 endothelial cells were kindly provided by Dr. David 
Kurjiaka (Grand Valley State University, Allendale, MI). Cells were grown at 37°C with 
10% CO2 in high glucose DMEM (HyClone) containing 10% FBS, penicillin and 
streptomycin (700μg/ml penicillin and 700μg/ml streptomycin) in 100mm plates. The 
media was renewed every 2-5 days until the cells reached 80% confluence or greater.  
Eosinophils: The HL-60 Clone 15-cell line was purchased from ATCC (American 
Tissue Culture Collection, Manassas, VA). The cells were maintained in RPMI 1640 with 
10% FBS (ATCC) and 50μg/ml gentamycin (Sigma).  The cells were induced to 
differentiate into eosinophils by seeding them at 2x105 cells/mL in medium containing 
0.5mM butyric acid (Sigma).  Cell culture was continued for 7 days without changing the 
medium. Cell viability was assessed by 0.2% trypan blue dye exclusion. To assess 
eosinophil differentiation, cells were stained with Luxol-Fast-Blue stain (Sigma), a dye 
that specifically stains mouse eosinophil granules (15, 16). An H&E stain was also 
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performed to verify the differentiation of the cells into eosinophils (courtesy of 
Dermatology Associates of West Michigan). Pictures were taken to demonstrate cell 
differentiation into eosinophils. (See Figure 6). 
Protein Sample Preparation  
Endothelial Cells: 100mm plate cultures of confluent bEnd.3 endothelial cells 
were placed on ice and washed 3 times with 5mL of cold phosphate buffered saline 
solution (PBS). The cells were then scraped into a 1mL volume of PBS (Corning Costar 
3008). The scraped contents were then transferred to a microcentrifuge tube and 
centrifuged at 7000xg for 5 minutes at 4°C. The supernatant (1X PBS) was removed and 
the cell pellet (whole cells) was resuspended in 50-100μL of 1X Laemmli sample buffer 
on ice. The mixture was sonicated twice at intensity 10 (Microson XL2000) for 15 
seconds and then placed back on ice. Next, the samples were spun down for 10 minutes at 
14,000xg in a 4°C centrifuge. The supernatant was transferred to a microcentrifuge tube 
and stored at -20°C until used.  
Eosinophils: HL-60 Clone 15 cells, either differentiated or undifferentiated, were 
centrifuged at 1200 RPM (about 800xg) for 8 minutes at room temperature. The 
supernatant was removed and the cells were washed three times in 5mL of cold PBS. 
After the final wash, the protein samples were prepared as described above for the bEnd.3 
cells.  
BCA assay of protein concentration 
 Protein concentration was measured using a standard BCA assay kit (Pierce), sample 
buffer (1X Laemmli sample buffer), and 1X PBS. 10μL of each sample was used to 
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determine the concentration of protein per sample.  Bovine serum albumin was used to 
generate a standard curve. 
Gel Electrophoresis 
A 10% SDS PAGE gel was prepared and 30-40μg of protein was loaded per lane 
Gels were run overnight at 6-8mA per gel. Proteins were then transferred to PVDF 
membranes and stored at 4°C until used for Western blotting.  
Western blot 
Membranes were blocked in 5% non-fat dry milk (Carnation) in Tris-buffered saline-
Tween (TBST) for 30 minutes. A calculated dilution (1:2000) of primary antibody was 
added directly into the milk solution and the membrane allowed to rock for 2 hours at 
room temperature or overnight at 4°C. The membranes were then washed with TBST 5 
times, rocking each wash for 5 minutes each.  Next, a goat anti-rabbit IgG conjugated to 
horseradish peroxidase (Sigma) was diluted 1:10,000 in 5% milk-TBST and incubated on 
the blot for 90 minutes at room temperature.  Membranes were then washed again with 
TBST as described. After the final wash, the chemiluminescent substrate (Pierce 
SuperSignal West Pico) was added to each membrane and rocked for approximately one 
minute to ensure that it covered the entire membrane. Membranes were then wrapped in 
Saran Wrap and exposed to X-ray film (Midwest Scientific) for both 10-15 minutes and 
overnight.    
Cell stimulation 
LPS was used at 10μg/ml to stimulate the cells for the time indicated. 10% BSA was 
created by dissolving 1 gram of low endotoxin BSA into 10mL of 1X PBS. The mixture 
was gently warmed and vortexed until the BSA completely dissolved into solution. The 
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final mixture was then sterile-filtered and stored in the refrigerator until used. Saturated 
fatty acids (SFA): 30mM stock solutions of SFA (palmitic, lauric and/or linoleic acid) in 
ethanol were prepared and stored at -20°C.  Stock solutions were diluted to 5mM-30mM 
working solutions by adding them in a 1:7 volume ratio to 10% fatty acid-free BSA in 
PBS.  The solutions were incubated for 1-2 hours at 37°C until all precipitations were 
completely dissolved, then sterile-filtered and stored in the refrigerator. The vehicle 
control used a mixture of ethanol and BSA alone in place of SFA. On the day of the 
experiment, a final SFA concentration of 100-800μM was used to stimulate the cells for 
0, 4 or 24 hours, based on the reported rat physiological range for serum non-esterified 
fatty acid levels from 100-200μM under non-fasting conditions to 500-600μM in fasting 
conditions (17). Equal volumes of control solution were placed into the other plates to 
ensure a similar environment for cell growth. This was done for the endothelial cells 
only.   
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Results 
 
 The bEnd.3 endothelial cell line is derived from the cerebral cortex tissue of 
mouse brain. According to the ATCC, these cells should express the following adhesion 
molecules: intracellular adhesion molecule 1(ICAM-1), vascular adhesion molecule 1 
(VCAM-1) & mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1). E & 
P-selectin can be induced by TNF-α, LPS or interleukin-1. These cytokines will also 
increase expression of ICAM-1 on the cells. Based upon these references from ATCC, as 
well as other studies, we assumed that the endothelial cells contained the necessary 
receptors (such as TLR-4) to respond with appropriate connexin expression (18, 19).  All 
experiments used bEnd.3 cells that were under passage 30.  
 
Time-dependent effects of LPS on Cx43 expression 
 Because LPS and SFA are able to both act through the TLR-4 receptor to induce 
inflammation, we wanted to test this to see if they produced a similar profile of connexin 
expression.  Hypothetically, LPS binding to the TLR-4 on the endothelial cells should up 
regulate Cx43 expression on endothelial cells. Therefore, we stimulated confluent bEnd.3 
endothelial cells with 10 μg/ml of LPS for 4 or 24 hours for comparison with SFA 
stimulation. We found that over a 24-hour time frame (after adjusting for the 
background), LPS increased Cx43 expression within 4 hours which then returned to 
control levels by 24 hours (Table 1). This was 57% higher than the vehicle control (Table 
1). Because the background intensity in the Western blots was not uniform throughout, 
Table 1 provides a quantitation of band intensity, with the background subtracted, for 
ease of comparison. 
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Figure 1: LPS Increases Cx43 expression in bEnd.3 endothelial cells. Confluent 
bEnd.3 endothelial cells were stimulated with 10μg/ml for 4 hours (lane 2) or 24 hours 
(lane 3) and the expression of Cx43 was analyzed by Western blot. The control is shown 
in lane 1.  
 
Time-dependent effects of palmitic acid on Cx43 expression 
 Palmitic acid (PA), a C16:0 SFA has been shown by others to bind to and activate 
endothelial cells through the TLR-4 receptor and to influence connexin expression.  This 
in turn regulates expression of endothelial leukocyte adhesion molecules (ELAMs) such 
as selectins and vascular cell adhesion molecule-1 (VCAM-1). PA has been reported to 
increase connexin 43 expression as well as ELAMs and its influence is proportionate 
with incubation time (20, 21). To confirm these reports in the bEnd.3 endothelial cells,  a 
low concentration (100μM) of palmitic acid was used to stimulated the cells for 4 and 24 
hours.  Connexin 43 expression was then compared between the treated and control cells.   
As shown in Figure 2, there appeared to be small changes in band intensity during the 
exposure to the palmitic acid. The 4-hour stimulation has a darker intensity than the 
control indicating a transient increase in expression followed by a decrease in expression 
by 24 hours (Figure 2). The data indicates a 34% increase in Cx43 expression after 4 
hours of exposure, which decreased to 14% at 24 hours (Table 1). This would suggest 
that a low concentration of palmitic acid is able to increase the expression of Cx43 by 
bEnd.3 endothelial cells within a 4-hour period in a manner similar to that seen with LPS. 
    1            2              3 
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Figure 2: Low concentration (100μM) of palmitic acid increases Cx43 expression by 
4 hours and decreases expression by 24 hours in bEnd.3 endothelial cells. Confluent 
bEnd.3 endothelial cells were stimulated with 100μM of palmitic acid for 4 hours (lane 2) 
or 24 hours (lane 3) and the expression of Cx43 was analyzed by Western blot. The 
control is shown in lane 1. 
 
Concentration dependent effects of palmitic acid on Cx43 expression 
 As mentioned above, palmitic acid has been shown to increase connexin 43 
expression as well as ELAMs and its influence is proportionate with incubation time (20, 
21). Since we did not see a sustained increase in Cx43 expression using 100μM, we 
tested the effects of higher concentrations of PA (100 - 400μM) on Cx43 expression in 
bEnd.3 endothelial cells at 24-hours. The 100μM stimulation for 24 hours had similar 
Cx43 expression as compared to the control group, consistent with the results in Figure 2. 
As concentration began to increase from 100μM to 400μM however, the intensity of the 
band greatly increased (Figure 3). According to the data provided in Table 1, while 
100μM and 200μM concentrations decreased Cx43 expression by 40% and 32% 
respectively compared to the control, the 400μM concentration increased expression by 
25% (Table 1). This suggests that a concentration of 400μM of PA for 24 hours is 
sufficient to elevate Cx43 expression in bEnd.3 endothelial cells.  Also noteworthy is that 
          1           2              3 
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the phosphorylated forms of Cx43 become stronger than the control after 24 hours of 
treatment with 400μM PA.  
 
 
 
 
 
 
 
 
 
Figure 3: High concentrations (400μM) but not low concentrations (100μM & 
200μM) of palmitic acid increase Cx43 expression in bEnd.3 endothelial cells within 
a 24-hour period. Confluent bEnd.3 endothelial cells were stimulated with 100μM (lane 
2), 200μM (lane 3) or 400μM (lane 4) of palmitic acid for 24 hours and the expression of 
Cx43 was analyzed by Western blot. The control is shown in lane 1. 
 
 
Concentration dependent effects of lauric acid on Cx43 expression 
 Lauric acid (LA), a C12:0 SFA, has not been investigated in terms of its effects 
on connexin or ELAM expression, but it has been shown to be a potent activator of TLR-
4 receptors in dendritic cells (22). In order to investigate the effect of chain length on the 
activity of SFA, lauric acid was used to treat the endothelial cell for comparison with 
palmitic acid.  We hypothesized that because lauric acid is a SFA, it should produce 
similar results to that of palmitic acid if they both engage the TLR-4 receptor. With this 
in mind, we evaluated the effects of 100 - 400μM lauric acid on Cx43 expression in 
bEnd.3 endothelial cells for 24-hours. The results indicate that as the concentration of LA 
increases, the expression of Cx43 steadily increases as well (Figure 4, Table 1). At 
400μM LA the expression of Cx43 in the bEnd.3 endothelial cells was 75% higher than 
the control (Figure 4,Table 1) after 24 hours of treatment. With this information we can 
              1           2                     3          4 
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conclude that SFA increases Cx43 expression in endothelial cells regardless of chain 
length. In both cases, Cx43 was increased after 24 hours of treatment, although there is 
some suggestion that the shorter chain LA may have more potent effects. 
 
 
 
 
 
 
 
 
Figure 4: Increasing concentrations (100-400μM) of lauric acid increase Cx43 
expression in bEnd.3 endothelial cells within a 24-hour period. Confluent bEnd.3 
endothelial cells were stimulated with 100μM (lane 2), 200μM (lane 3) or 400μM (lane 
4) of lauric acid for 24 hours and the expression of Cx43 was analyzed by Western blot. 
The control is shown in lane 1. 
 
 
 
 
Concentration dependent effects of linoleic acid on Cx43 expression 
 Unsaturated fatty acids are known to bind to the PPARγ nuclear receptor to 
reduce inflammation by interfering with the de-repression of inflammatory cytokine gene 
transcription. Since saturated and unsaturated fatty acids are expected to have opposite 
effects on connexin 40 and 43 expression, we evaluated the effects of various 
concentrations of linoleic acid (LnA) on Cx43 expression in bEnd.3 endothelial cells. 
Because LnA is an UFA, we hypothesized that it would act like other UFAs such as the 
omega-3 alpha-linolenic acid and reduce Cx43 expression in a non-time dependent 
manner (20, 23, 24).  
According to Figure 5a and Table 1 combined, it can be seen that the 100μM 
stimulation over 24 hours resulted in an increase in Cx43 expression (30%). Similarly, 
         1               2                3                4 
 13 
the 200μM stimulation resulted in a darker, more intense band while the 400μM 
stimulation was actually less intense than the control and lower concentrations of LnA 
(Figure 5a). After adjusting the data for any background differences, we found that at 
200μM of LnA that Cx43 expression began to decrease as compared to the 100μM 
stimulation (17%) but was still 13% higher than the control (Table 1).  In contrast, the 
400μM stimulation decreased expression of Cx43 by 33% (Table 1).  This fairly 
significant decrease in Cx43 expression at the higher concentration of LnA led us to 
further explore even higher concentrations of LnA on bEnd.3 endothelial expression of 
connexins. Figure 5b and Table 1 indicate that the effects of 400μM LnA on Cx43 
expression were negligible in this trial; however, 800μM of LnA resulted in a 36% 
decrease in Cx43 expression as compared to the control. While there is still some 
variability or inconsistency in the trials conducted, we can generally conclude that 
stimulation using high concentrations of LnA for 24 hours decreases Cx43 expression in 
bEnd.3 endothelial cells. This is of interest as the effects of LnA on connexin expression 
have been controversial (20, 23, 24) 
 
 
 
 
 
 
 
 
Figure 5a: High concentration (400μM) but not low concentrations (100μM & 
200μM) of linoleic acid decrease Cx43 expression in bEnd.3 endothelial cells within 
a 24-hour period. Confluent bEnd.3 endothelial cells were stimulated with 100μM (lane 
2), 200μM (lane 3) or 400μM (lane 4) linoleic acid for 24 hours and the expression of 
Cx43 was analyzed by Western blot. The control is shown in lane 1.  
 
            1            2            3                   4 
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Figure 5b: Increasing concentrations (400μM to 800μM) of linoleic acid decrease 
Cx43 expression in bEnd.3 endothelial cells within a 24-hour period. Confluent 
bEnd.3 endothelial cells were stimulated with 400μM (lane 3) or 800μM (lane 4) of 
linoleic acid for 24 hours and the expression of Cx43 was analyzed by Western blot. The 
control with regular media is shown in lane 1 and control with ETOH-BSA is shown in 
lane 2.  
 
 
 
 
 
Lane Time (hrs) Concentration Total Intensity Ratio to Control Result 
 
1 Control 0 19723 
 
  
A 2 4 LPS 10 μg/ml 31055 1.57 Increase 
 
3 24 LPS 10 μg/ml 18434 0.93 No change 
 
1 Control 0 15495 
 
  
B 2 4 100 μM PA 20750 1.34 Increase 
 
3 24 100 μM PA 13264 0.86 Decrease 
 
1 Control 0 15287 
 
  
C 2 24 100 μM PA 9366 0.61 Decrease 
 
3 24 200 μM PA 11882 0.78 Decrease 
 
4 24 400 μM PA 19052 1.25 Increase 
 
1 Control 0 10656 
 
  
D 2 24 100 μM LA 15797 1.48 Increase 
 
3 24 200 μM LA 16292 1.53 Increase 
 
4 24 400 μM LA 18636 1.75 Increase 
 
1 Control 0 15287 
 
  
E 2 24 100 μM LnA 19842 1.30 Increase 
 
3 24 200 μM LnA 17208 1.13 Increase 
 
4 24 400 μM LnA 11845 0.77 Decrease 
 
1 Control 0 11793 
 
  
F 2 Vehicle ETOH BSA 12918 1.10 No change 
 
3 24 400 μM LnA 11320 0.96 No change 
 
4 24 800 μM LnA   7505 0.64 Decrease 
 
Table 1: Western blot band quantitation adjusted for differences in background 
intensities. A-F corresponds with the sequence in which the results are presented above. 
(Abbreviations: PA = palmitic acid, LA = lauric acid, LnA = linoleic acid) 
             1             2            3             4 
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Expression of connexins on eosinophils 
 Immune cells such as macrophages have been shown to express connexins, 
including Cx37 (12, 14). The expression of this specific connexin in an inflammatory 
environment allows the macrophage to release ATP, which has downstream effects of up-
regulating ELAM expression on endothelial cells (12, 14). Because eosinophils have 
some similarities to macrophages in terms of migration, it is possible that eosinophils also 
express connexins to modify endothelial expression of ELAMs. This might explain why 
eosinophils are unable to migrate into inflamed adipose tissues.  
 HL-60 Clone 15 leukemic cells have been shown in the literature to serve as an 
in vitro model of eosinophils. These cells can be differentiated to eosinophils by 
treatment for seven days with butyric acid (15).  Using this protocol, the differentiated 
cells were analyzed by Western blot for the expression of Cx37 and Cx43, the two 
connexins known to be involved with release of ATP onto the endothelial surface. The 
control, which consisted of a non-differentiated HL-60 Clone 15 leukemic cell produced 
the same results. This led us to conclude that eosinophils differentiated from the HL-60 
Clone 15 cell line do not express connexins. Confirmation that the cell line differentiated 
into eosinophils was determined by staining with Luxol-Fast-Blue stain and by H&E 
staining. (Figure 6).  
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Figure 6: A) 7 day butyric acid differentiated HL-60 Clone 15 cell into an 
eosinophil, H&E Stain. B) Differentiated, Luxol-Fast-Blue stain C) Non-
differentiated HL-60 Clone 15 cell, Luxol-Fast-Blue stain 
 
 
Expression of Cx40 and Cx37 by bEnd.3 endothelial cells 
 The expression of connexins 40 and 37 were investigated in bEnd.3 endothelial 
cells in a similar fashion to Cx43. Unfortunately, we were unable to identify any 
expression of either connexin with unstimulated cells. Cx40 expression was continually 
evaluated in each experiment along with Cx43 but we failed to find any indication of 
Cx40 expression.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B C 
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Discussion 
 
 In this study the effects of SFA and UFA on the expression of endothelial 
connexin 43 were investigated as a potential means to alter eosinophil transendothelial 
migration. We also looked at Cx37 and 40 expression but were unable to detect these 
proteins. We predicted that LPS as well as any chain length of SFA would increase Cx43 
expression and thereby promote eosinophil transmigration since these are all ligands for 
TLR-4. Conversely, we expected linoleic acid, an UFA, to decrease Cx43 expression and 
therefore prevent eosinophil migration across the endothelial barrier.  
 The results support the hypothesis in that both long (PA) and short chain (LA) 
SFA were able to increase the expression of Cx43 in bEnd.3 endothelial cells. Increasing 
LA concentrations resulted in increasing Cx43 expression while PA only increased 
expression at higher concentrations (400μM) (Table 1). This concentration of palmitic 
acid represents the high end of the physiological range for rodents (100μM to 600μM) 
and is much higher than the normal, nontoxic blood concentration of free fatty acids in 
humans (10-30µM) (17, 20).  However, any concentration of PA below 400μM resulted 
in a decrease in expression of Cx43 (Table 1). We also found that higher concentrations 
(400-800μM) of a polyunsaturated fatty acid (linoleic acid) led to a decrease in Cx43 
expression in bEnd.3 endothelial cells. Some other findings included an increase in Cx43 
expression in response to LPS and also that differentiated HL-60 Clone 15 eosinophils do 
not express connexins 37 or 43. 
 This data provides evidence to suggest that fatty acids might be involved in 
modulating the expression of adhesion molecules on the endothelial surface in diet-
induced obese individuals. Excess SFA in the diet-induced obese individual could 
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increase connexin 43, leading to endothelial leukocyte adhesion molecule (ELAM) 
expression (VCAM-1 and selectins) that would prevent eosinophils from migrating into 
the inflamed tissue. A simple change in diet, incorporating more UFA such as omega 3 
and omega 6 fatty acids, could reverse this change by decreasing connexin 43 expression. 
Eosinophils would then attach to the endothelium and extravasate due to a higher 
expression of ICAM-1 than VCAM-1. Also, the fact that eosinophils do not appear to 
express connexins supports the idea that fatty acids might directly modulate ELAMs on 
the endothelium without contribution by the eosinophils themselves. 
  Our results are in agreement with the work of others. For example, it has been 
found that SFA are associated with increased ELAM expression on endothelial cells as 
well as with increased connexin 43. While lauric acid has not been previously studied, 
our results with palmitic acid are in agreement with other studies (20, 21, 26).  This data 
indicates that SFA of different chain lengths is able to act on endothelial cells through the 
appropriate receptor and modulate their state of activation by increasing expression of 
Cx43 (Figures 3 & 4).  This would be associated with either a loss of inhibition or a 
promotion of expression of endothelial leukocyte adhesion molecules such as VCAM-1 
or various selectins (21). Hypothetically, eosinophils would still be able to attach to the 
activated endothelium but expression of VCAM-1 might override that of ICAM-1, thus, 
preventing the eosinophil from detaching to migrate across the endothelial barrier (21, 27, 
28). This is because VCAM-1 is required for initial attachment of the eosinophil to the 
endothelium and for its activation.  However, a subsequent conformational change and 
decrease in VCAM-1 affinity is necessary while simultaneously increasing affinity for 
ICAM-1.  The increased binding of eosinophils to ICAM-1 allows the cells to undergo 
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diapedesis and cross the endothelial barrier.  Without being able to cross the endothelium, 
the eosinophils would not be available to secrete the cytokines needed to maintain the M2 
macrophage population, thus favoring the default activation of monocytes and 
macrophages towards the M1 macrophage state due to the molecular environment within 
the adipose tissue (6, 7). 
 The effects of UFA, specifically omega 6 fatty acids such as linoleic acid or 
arachidonic acid, on ELAMs such as VCAM-1 and ICAM-1 are controversial.  There are 
some reports that have shown no effect while others have shown an increase or decrease 
in adhesion molecule expression (14, 20, 21, 23).  Our data indicates that linoleic acid 
decreases Cx43 expression in bEnd.3 endothelial cells (Figure 5).  A decrease in Cx43 
expression would result in a subsequent decrease in expression of VCAM-1 and 
endothelial-expressed selectins, with ICAM-1 expression remaining relatively constant 
(21, 27, 28). Although VCAM-1 would be decreased, it is possible that there would still 
be enough expression for eosinophils to attach to the endothelium. With a higher ratio of 
ICAM-1 to VCAM-1, the eosinophils would be able to easily release VCAM-1 and bind 
to ICAM-1, allowing them to migrate across the endothelial barrier and enter the adipose 
tissue. 
 If the eosinophil is able to migrate into adipose tissue then it should be able to 
produce the necessary cytokines to maintain the M2 population within the specific tissue 
(28). Maintenance of M2 macrophages would result in a healthy balance of anti-
inflammatory molecules and prevent complications such as insulin resistance and 
adipocyte death from occurring (6, 7).  
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 Areas of improvement for this study would include the use of a positive control 
for Cx43 expression to further validate the Cx43 Western blots.  Additional experiments 
to directly detect the cellular adhesion molecules expressed in response to SFA and UFA 
stimulations would confirm our assumption that modulation of connexin affects ELAM 
expression.  Other avenues of interest to strengthen the study would be to investigate the 
effects of an omega-3 fatty acid on connexin expression as these are proven to be the 
most beneficial fatty acids and have anti-inflammatory properties as compared to omega-
6 fatty acids (20, 23, 24). Finally, combinations of SFA with LPS, UFA with LPS and 
SFA with UFA might contribute additional useful information, as would the use of 
additional concentrations of fatty acids and longer stimulations.  
 Although the HL-60 Clone 15 cell line has been shown by others to differentiate 
into eosinophils using the treatments used in this study, our efforts to confirm this 
differentiation were disappointing.  This causes us to proceed rather cautiously with any 
conclusions about connexin expression and function in eosinophils.  It would be desirable 
to repeat the experiments with primary human eosinophils or with a human eosinophil 
cell line.   
 To conclude, connexin expression can in fact be altered by fatty acids. SFA such 
as palmitic and lauric acid serve to increase connexin 43 expression while UFA like 
linoleic acid appear to decrease Cx43 expression at higher concentrations similar to those 
of a diet-induced obese individual. With further investigation, manipulation of connexin 
expression may be a key strategy for altering endothelial cell activation and leukocyte 
adhesion to combat pathologies associated with diet-induced obesity.  
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I. Diet-Induced Obesity and Type 2 Diabetes Mellitus 
Introduction 
At least 2.8 million adults worldwide die each year as a result of being overweight 
or obese. In addition, obesity contributes to 44% of those with diabetes, 23% of those 
with ischemic heart disease and 7% to 41% those with cancer (1).  With the doubling of 
the rates of obesity worldwide within 3 decades (1), the overall health problems 
associated with obesity can be viewed as life threatening. For example, obesity is a 
known risk factor for the development of diabetes. In fact, obesity is strongly associated 
with type-2 diabetes (2). This is of interest because diabetes, in turn, can also have 
serious health implications aside from obesity. Examples of health problems related to 
diabetes are increased risk of blindness, heart attacks, strokes and kidney failure. 
Diabetics also have twice the risk of death as compared to non-diabetics. Thus, diabetes 
poses many threats to one’s health.  
The link between type-2 diabetes and obesity is reflected in the updated definition 
of obesity as a state of chronic low-grade inflammation (3). This inflammation is a result 
of the difference in diets between individuals: a diet rich in saturated fatty acids (SFA) 
enhances inflammation whereas a diet rich in unsaturated fatty acids (UFA) reduces 
inflammation (3, 4, 5).
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Toll-Like Receptor 4 and its Associated Ligands 
When an individual consumes a diet rich in saturated fat, the result is an increase 
in circulating free SFAs. These free SFA activate Toll-like Receptor 4 (TLR-4) receptors 
on macrophages (6, 7, 8) similar to the lipopolysaccharides (LPS) that are released by 
invading bacteria. SFAs are structurally similar to LPS and therefore are both bound by 
the pattern recognition receptor (7) TLR-4. The binding of either ligand to the TLR-4 
receptor causes the secretion of inflammatory cytokines (6, 7).  
 
Saturated Fatty Acid Levels 
There are three reasons for the increase in free SFA concentration when 
consuming a high fat diet. The first is simply the naturally associated increase in levels of 
saturated fat within the body when consistently consuming a diet high in saturated fat. 
For example, normal, nontoxic, physiological blood concentrations of free fatty acids 
average from 10-30 µM; therefore, concentrations greatly exceeding this value would be 
considered unhealthy (9). When these concentrations of SFA are high in a cell, it can 
enhance their release in 2 ways: due to endoplasmic reticulum stress response and 
adipose tissue hyperplasia (7).  
Excess glucose and fatty acids (FA) are usually stored as triacylglycerides for 
later use, leading to their accumulation in adipose tissue. When an individual continues to 
consume excess calories, the “storage capacity” for triacylglycerides within adipocytes 
can be exceeded. The accumulation of fatty acid within cells increases their binding to 
fatty acid-binding protein (FABP/AP2). This FABP/AP2 alters the endoplasmic 
reticulum (the endoplasmic reticular stress) initiating an Unfolded Protein Response 
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(UPR). The UPR can also be stimulated by excess nutrients and microhypoxia that results 
when nutrient and oxygen supply become insufficient for the hyperplastic tissue (6, 7, 
10). Initiating a UPR activates the transcription factor nuclear factor –kappa B (NF-kB), 
which increases the production of inflammatory cytokines by the adipocytes (6, 7, 10). At 
the same time, the insulin-signaling pathway is inhibited through the serine 
phosphorylation of the Insulin Receptor Substrate 1 (IRS-1: discussed later). Further, 
activation of the UPR will cause the adipocyte to undergo apoptosis (programmed cell 
death). However, prior to apoptosis, the adipocyte will attract macrophages through the 
release cytokines like monocyte chemotactic protein 1 (MCP-1) due to both the activation 
of the UPR as well as nutrient overload that exceeds the rate at which the adipocyte can 
dispose of the fatty acids and results in accumulation of fatty acids within the tissue (11, 
12). 
In addition to the ER stress response, the accumulation of adipose tissue begins to 
exceed the capacity of the vascular supply to provide oxygenation. When the adipose 
tissue becomes hypoxic, necrosis (cell death) of the adipose tissue results, leading to 
outcomes similar to those associated with the ER stress response (6, 7, 10). 
 
The Insulin Response 
In a lean individual, the insulin response is initiated by insulin binding to its 
receptor, a tyrosine kinase, on the surface of the adipocyte, or any other cell/tissue, which 
activates intracellular substrates, referred to as insulin receptor substrate-1 and 2 and the 
mitogen-activated protein kinase (MAPK) cascades. These substrates are phosphorylated 
and activate phosphatidylinositol 3-kinase (PI3K). PI3K activation leads to the 
phosphorylation and activation of the protein kinase B (PKB)/Akt which translocate the 
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glucose transporter 4 (GLUT4) to the plasma membrane of the adipocyte. This allows for 
the uptake of glucose by the adipocyte and of its conversion to glycogen and fatty acids 
within the adipocyte (13, 14, 15). 
For an individual consuming a diet high in SFAs, the risk of developing a 
resistance to insulin that defines type 2 diabetes is elevated.  This is due to the release of 
inflammatory cytokines tumor necrosis alpha, interleukin 1 beta and interleukin 6 (TNF-
α, IL-1β and IL-6) by M1 macrophages in response to activation of the TLR-4 receptor 
by LPS or SFA. Once released within adipose tissue, these inflammatory cytokines can 
interfere with the insulin-signaling cascade. This causes insulin resistance within the 
resident tissue. The current finding for the development of insulin resistance is that these 
cytokines, as well as SFA and other inflammatory related molecules, stimulate the 
phosphorylation of c-Jun N-terminal kinase (JNK) and inhibitor of nuclear factor kappa 
beta kinase (IKKβ: 22). Phosphorylation of these transcription factors contributes to 
insulin resistance in 2 ways.  
First, activation of IKKβ and JNK by inflammatory mediators inhibits the activity 
of IRS-1: serine phosphorylation of IRS-1 dampens the normal insulin signaling pathway. 
This prevents activation of PI3K and thereby reduces the resulting translocation of 
GLUT4 to the plasma membrane of the adipose cell. Second, the production of 
inflammatory cytokines is elevated (25) (Figure 1). These two outcomes both contribute 
to insulin resistance and poor glucose metabolism because GLUT4 is not inserted into the 
membrane and this negatively affects glycogen synthesis. 
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Fig. 1: Intracellular mechanisms of inflammatory insulin resistance. Insulin action is 
transduced from the cell surface to cytoplasmic and nuclear responses via tyrosine 
phosphorylation of insulin receptor substrate (IRS)-1 and -2. However, serine 
phosphorylation of these same substrates by Jun N-terminal kinase 1 (JNK1) and 
inhibitor of nuclear factor κB (NF-κB)–kinase β (IKKβ), the central mediators of 
stress and inflammatory responses, potently inhibits insulin action, thereby directly 
linking these responses to insulin resistance. In addition, the transcriptional 
activation of inflammatory genes by JNK1 and IKKβ induces insulin resistance in 
an autocrine and paracrine manner in tissues. Moreover, in states of obesity, JNK1 
and IKKβ signaling pathways are activated by an increased influx of free fatty acids 
and glucose. Abbreviations: AP1, activator protein 1; ER, endoplasmic reticulum 
(7).  
 
II. The Macrophage 
M1 vs. M2 Macrophages and the Inflammatory Response 
When monocytes leave the blood and enter the tissues, they differentiate into a 
macrophage. When this differentiation occurs, the cytokine environment within the 
designated tissue will dictate whether the monocyte becomes an M1 or M2 macrophage.  
This is important as it determines the cytokines the macrophage will secrete upon 
activation. 
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For example, when there is a rise in SFA levels, individuals consuming a diet rich 
in SFA will exhibit two associated changes that occur with the macrophage. The first 
occurs when the macrophage is activated through the binding of LPS or SFA with the 
TLR-4 receptor to produce and secrete several inflammatory cytokines. This leads to the 
polarization of the macrophages to become M1 macrophages that will secrete pro-
inflammatory cytokines like TNF- α, IL-6 and IL-1β that are responsible for the 
development of insulin resistance (2, 3, 7, 16, 17). Therefore, the M1 macrophage can be 
characterized as a pro-inflammatory macrophage whose abundance correlates with free 
SFA levels and contributes to insulin resistance (6) (Figure 2).  
The second associated outcome is the down regulation of the peroxisome 
proliferator-activated receptor (PPAR). PPAR is a nuclear membrane receptor expressed 
by the M2 macrophage whose ligands are UFAs (6, 7). When activated by UFAs they 
lead to the production of anti-inflammatory cytokines such as IL-10. Recently IL-10 was 
shown to decrease inflammation and (more importantly) increase insulin sensitivity, 
although the mechanism of action is unclear (13, 16). PPAR consists of a gamma, alpha 
and beta/delta form (PPARγ, PPARα, & PPARβ/δ) and these different forms are up-
regulated on the macrophage nuclear membrane surface in response to Interleukins-4 and 
13 (IL-4 and IL-13) binding to their receptors on the macrophage. These two cytokines 
are produced by several types of immune cells including eosinophils (6, 16). Without 
these cytokines, PPAR expression would not increase within the macrophage (7).  
In light of the discussion above, UFA and SFA are best viewed as competitors. 
When concentrations of SFA are higher than UFA, there will be more activated M1 than 
M2 macrophages within adipose tissue due to the down regulation of the PPARγ receptor 
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and pro-inflammatory cytokines secretion. This increases the inflammatory response 
within adipose tissue and ultimately leads to the development of insulin resistance (6, 
16). Conversely, if concentrations of UFA are greater than that of SFA, as with lean 
individuals, there will be more activated M2 than M1 macrophages in adipose tissue due 
to the binding of UFA to PPARγ in macrophages. This will lead to the down regulation 
of the inflammatory cytokine genes and promote the production of anti-inflammatory 
cytokines  (Figure 2) (6, 7, 16).  
 
The M2 Macrophage Response 
The energy substrate utilized by macrophages is affected by the presence 
prevailing fatty acids. When the UFA binds to the PPARγ receptor, it redirects the energy 
metabolism of the M1 macrophage towards a more glycolytic pathway. The M1 
macrophage relies on a glycolytic program to rapidly provide the energy and reducing 
equivalents necessary for intense, short-lived bactericidal activity. However, when UFA 
engages with the PPARγ receptor, the macrophage’s energy program shifts to the more 
efficient and sustainable fatty acid oxidation and oxidative glucose metabolism program 
associated with the M2 macrophage. This enhances the oxidative metabolism of the M2 
macrophage, facilitating the break down of fat by phagocytosis of free fatty acid and 
reduction of fatty acid levels within the adipose tissue (6).  Therefore, a lean individual 
consuming a diet rich in UFA will have less fat due to the response created by the ligand-
receptor relationship between UFA and PPARγ which would in turn reduce SFA levels in 
adipose tissue.  
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The binding of UFA to PPARγ within M2 macrophages in adipose tissue also 
negatively regulates components of the inflammatory pathway such as NF-kB to reduce 
the production of inflammatory cytokines. This involves two inflammatory gene 
suppressors Nuclear Receptor Corepressor (NCoR) and Silencing Mediator of Retinoic 
acid and Thyroid hormone receptors (SMRT). These suppressors are normally bound to 
inflammatory cytokine transcription activators and are removed in response to activation 
of the TLR-4 receptor. When PPARγ is activated by UFAs, a small intracellular portion 
of the receptor covalently couples with SUMO1, which is a small ubiquitin-like modifier. 
This leads to the “SUMOylation” of PPARγ which independently associates with the 
inflammatory gene, hindering the removal of NCoR and SMRT.  Because the 
NCoR/SMRT complexes are not removed from inflammatory cytokine transcription 
activators, the expression of inflammatory cytokines cannot occur. This would favor the 
M2 phenotype over M1 macrophages within adipose tissue and allow for an increased 
number of M2 macrophages due to the higher probability of their activation. Once again, 
this would lead to the break down of more fat, the production of the insulin-sensitizing 
interleukin-10 and a decrease in the inflammatory cytokine levels that contribute to 
insulin resistance (Figure 2) (6).  
When UFA concentrations rise in individuals who have a healthier diet, it is 
important that M2 macrophages express the corresponding PPARγ receptor in order to 
respond.  This PPARγ expression is dependent upon IL-4 and IL-13, which are produced 
by immune cells such as eosinophils in adipose tissues. These cytokines bind to the 
corresponding receptors on the macrophage to induce expression of PPARγ. By 
increasing the presence of PPARγ in the macrophage these cytokines increase the 
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availability of PPARγ receptor and directing the macrophage to the M2 phenotype. By 
increasing the number of M2 macrophages in adipose tissue, IL-4 and IL-13 decreased 
SFAs and inflammatory cytokine levels within adipose tissue while also enhancing 
insulin sensitivity (6, 7).  
In summary, the consistent presence of SFA associated with a high fat diet will 
activate M1 macrophages in adipose tissue through TLR-4 leading to the secretion of 
inflammatory cytokines TNF- α, IL-6 and IL-1β. This contributes to insulin resistance. 
Simultaneously, PPARγ receptor expression is decreased and thus the presence of the M2 
macrophages in adipose tissue will decline as they become converted to M1 macrophages 
and inflammation and insulin resistance become dominant (6, 7, 16).  
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Fig. 2: The M1 macrophage is activated by Pathogen Associated Molecular Patterns 
(PAMPs) such as LPS and SFA and by IFN-γ. The M2 macrophage is activated by 
IL-4 and IL-13 which are produced by Eosinophils, Basophils and NK cells. This 
leads to continued M2 production and associated secretion of IL-10 (6).  
 
 
III. Eosinophils & Endothelial Cells 
The Eosinophil, Eosinophil Migration and Connexins 
Given this information, the transformation from M1 to M2 macrophages appears 
to be critical for reducing inflammation resulting from diet-induced obesity. In theory, 
this re-polarization could be accomplished by exposure to IL-4 and IL-13. These 
cytokines would induce PPARγ expression to convert macrophages to the M2 phenotype, 
promoting insulin sensitivity and combating the insulin resistance associated with type-2 
diabetes. However, the source of these cytokines within healthy (UFA dominant) adipose 
tissue has been unclear, as has the reason for their reduced production in the obese 
individual.  Recent work suggests that the source of the cytokines is eosinophils (18). 
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Eosinophils play a major role in sustaining M2 macrophage numbers in adipose tissue by 
secreting a majority of the IL-4 present in perigonadal adipose tissue mice (18, 19). The 
reason for the reduced secretion of IL-4 and IL-13 in the adipose tissue of obese 
individuals has yet to be resolved but may involve the eosinophil. The eosinophils present 
in adipose tissue may be stimulated by SFAs or inflammatory cytokines to produce less 
IL-4 and IL-13. They might also be stimulated to secrete inflammatory by SFA binding 
to the TLR-4 receptors (20). Alternatively, the eosinophils might be dying off within the 
adipose tissue, as TNF- α can stimulate eosinophil apoptosis (16). Further, as the 
eosinophil must cross the endothelium to reach the adipocyte, a decrease in eosinophils / 
endothelial cells interaction would reduce eosinophil migration into adipose tissue. This 
study will focus on the effects of free SFA on the migration of eosinophils. 
 
Eosinophil Transmigration 
Eosinophils migrate in a similar manner to other leukocytes, which involves a 
three-step process. First, selectins expressed on the eosinophil and endothelial cell 
loosely tether these cells to reduce eosinophil velocity in the blood. This slow, rolling 
eosinophil begins to expresses integrins that bind to cellular adhesion proteins on the 
endothelium to prevent further rolling (firmly adhere to endothelium). This interaction of 
the integrins with the endothelial adhesion proteins is further strengthened by the 
chemokines that attracted the eosinophil to the inflamed tissue. Finally, adhesion ligands 
in combination with chemokines secreted by cells in the surrounding tissue activate the 
eosinophil and attract the eosinophil into specific tissues (21, 22, 23, 24).  
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Three selectins are expressed on the endothelium, and some leukocytes, that are 
involved in transendothelial migration of eosinophils: selectins L, E and P. L-selectin is 
expressed on eosinophils and P and E-selectins are expressed on endothelial cells (21). 
Eosinophil rolling is dependent on P-selectin. The expression of this integral membrane 
protein is stimulated by cytokines IL-4 and IL-13. This is important as an environment 
saturated with UFA and a large M2 macrophage population has higher levels of these two 
cytokines thus leading to increased eosinophil migration to the specific tissue. Also, this 
selectin is longer than the other two selectins, which allows the endothelium to capture 
more leukocytes (21). L-selectin plays a role in the initial recruitment and attachment of 
the eosinophil (21, 23, 24).  
The primary ligand for P-selectin is P-selectin glycoprotein ligand 1 (PSGL-1); 
CD24 expressed on eosinophils is also a receptor for this selectin. The eosinophils favor 
binding to P-selectin due to the higher levels of PSGL-1 on their surface as compared to 
sialyl Lewis x (E-selectin or L-selectin ligand).  In addition, the inflammatory 
environment with TNF-α present would enhance the role of P-selectin in initial 
attachment of eosinophils to the endothelium (16, 21, 25, 26, 27). 
 Another eosinophilic protein involved in tethering to the endothelium is very late 
antigen-4 (VLA-4 or alpha4 beta1 integrin).  This proteins binds to the vascular cell 
adhesion molecule-1 (VCAM-1) on the endothelial cells. This interaction is key to 
eosinophil recruitment as blocking VLA-4/VCAM-1 interaction reduces eosinophil 
migration across endothelial monolayers within minutes but has no effect over longer 
periods of time (21, 23, 24). This interaction is also able to mediate eosinophil migration 
across the endothelial barrier (23, 24). Aside from VLA-4, eosinophils also express an 
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α4β7 integrin receptor on their surface that binds to its principle ligand MAdCAM-1, 
primarily expressed in mucosal tissues (e.g., gastrointestinal tract) and contributes to 
diseases of altered eosinophil recruitment (21, 25). 
Although VCAM-1 is important in eosinophil migration, binding to the 
endothelium can also be independent of VCAM-1, relying solely on P-selectin and 
intracellular adhesion molecule 1 (ICAM-1: 23, 24, 28). ICAM-1, an adhesion 
molecule/β2 integrin ligand, is expressed both on the luminal surface of the endothelial 
cell as well as between adjacent cells. The abundance of ICAM-1 on the surface of the 
endothelial allows eosinophils migration across the endothelial barrier without the use of 
VCAM-1 as VCAM-1 is expressed only on the luminal surface (23, 24).  Blocking the 
interaction between endothelial ICAM-1 and β2 integrins on eosinophils prevents the 
eosinophil from migrating across the endothelial barrier. Therefore, the VLA-4/VCAM-1 
interaction is necessary for recruitment and initial attachment of the eosinophil but 
ICAM-1 is required for eosinophil arrest and migration across the endothelium (23, 24).   
 Once the eosinophils are arrested by the endothelium, they must then be activated 
(i.e., change cytoskeletal conformation and expression of adhesion molecules) in order to 
create the firm endothelial adhesion that allows transmigration. This involves the binding 
of VLA-4 to VCAM-1 which activates several intracellular pathways within eosinophils 
through phosphorylation of Cbl, a protein product of the c-cbl proto-oncogene, and 
Phospholipase C (PLC) (See Figure 3). Cbl activates ZAP-70 and PLC-γ, which can play 
a role in adhesion-dependent functions of eosinophils. Activation of the eosinophil 
through VLA-4 and VCAM-1 interaction also enhances the generation of superoxide 
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anions by the eosinophil resulting in activation of the eosinophil’s VLA-4 receptor (23, 
24, 29, 30).  
 
 
  
Fig. 3: Activation of β2 integrin receptors like LFA-1 and MAC-1 on eosinophils 
leads to the activation of two different intracellular pathways. Activation of both the 
IP3 and PKC pathways lead to eosinophil activation and subsequent degranulation. 
 
The activation of VLA-4 increases eosinophil binding to VCAM-1 through 
enhanced affinity for the VCAM-1 on the endothelium creating a positive feedback 
mechanism. After this process of firm adhesion begins, the eosinophil undergoes a 
β2 Integrin Receptor 
Clustering 
Phosphorylation of PLC 
Hydrolysis of phosphatidylinositol 4,5-biphosphate 
Inositol 1,4,5-Triphosphate (IP3) 
Intracellular Calcium mobilization 
Diacylglycerol (DAG) 
Protein Kinase C (PKC) 
Degranulation  
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conformational change via activation through surface adhesion proteins such as the α4 
and β2 integrins MAC-1 and LFA-1 (CD11b/18 and CD11a/18) and ICAM-1 on the 
endothelial cells. These interactions mediate eosinophil adhesion to the endothelium by 
supporting the activation of the β2 integrins, through the conformational change, on the 
eosinophil further enhancing the interaction with the abundant ICAM-1 on the 
endothelium. This activation signal can result from selectin binding, the interaction of the 
eosinophil with VCAM-1 or soluble factors like chemokines (Platelet Activating Factor 
and RANTES) or cytokines (TNF-α) (21, 23, 24). Also noteworthy is that ICAM-1 can 
be expressed by eosinophils and interact with similar receptors on the endothelium, thus 
the interaction can go either way (31). This process is summarized in figure 4. 
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Fig. 4: Eosinophil recruitment and transmigration across the endothelial barrier.  
The eosinophil is first recruited to the specific tissue by chemokines resulting in a 
decrease in eosinophil velocity within the blood and allows the eosinophil to roll 
along the endothelial lining. Selectins on the eosinophil further reduce eosinophil 
velocity by grabbing, not binding, onto carbohydrates on the luminal surface of the 
endothelium. Upon tethering, the interaction between VLA-4 on the eosinophil and 
VCAM-1 on the endothelium occurs and begins the process of firm adhesion while 
simultaneously activating the eosinophil. The activation of the eosinophil results in a 
conformational change in the eosinophil’s cytoskeleton promoting β2 integrin 
interaction with ICAM-1 on the endothelium. This final interaction results in the 
degranulation of the eosinophil leading to enhanced interaction between β2 integrin 
and ICAM-1 and finally results in diapedesis of the eosinophil and complete 
migration across the endothelial barrier (75, 76). (E = eosinophil, Endo = 
endothelium, ECP = eosinophil cationic protein, EDN = eosinophil-derived 
neurotoxin) 
 
 
 
Reduced Eosinophil Velocity • Chemoattractants [Eotaxin-1 & RANTES] 
Eosinophil Tethering • Selectins (E) + Carbs (Endo) 
Attachment, Firm 
Adhesion & β2 Integrin Activation • VLA-4 (E)+ VCAM-1 (Endo) 
Eosinophil Conformational Change • Eosinophil Arrest & Activation • β2 Integrin (E) + ICAM-1 (Endo) 
Enhancement of 
β2 Integrin (E) & ICAM-1 (Endo) Interaction • Eosinophil Degranulation (ECP & EDN) 
Diapedesis 
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Influences on Integrin Expression or Binding 
After the interaction between eosinophil β2 integrins and endothelial ICAM-1, 
activation of a tyrosine kinase and phosphoinositide metabolism in the eosinophil causes 
their degranulation and release Eosinophil Cationic Protein (ECP) and eosinophil-derived 
neurotoxin. These products enhance the expression of endothelial ICAM-1, further 
strengthening the interaction between endothelium and eosinophil.  
 Once tightly bound to the endothelium, eosinophils transmigrate, which requires 
β2 integrins on the surface of the eosinophil. Specifically, this process requires the 
interaction of LFA-1 and Mac-1 integrins with their endothelial receptors ICAM-1 and 
ICAM-2. The interaction between VLA-4 and VCAM-1 (a β1 integrin) partially inhibits 
eosinophil transmigration: as eosinophils are activated, their cellular adhesion molecules 
switch their preference, through a cytoskeletal conformation changes their affinity from 
VCAM-1 to ICAM-1 which allows transendothelial migration (21, 23, 24). 
 The eosinophil must also be primed in order to transmigrate. This priming occurs 
through the binding of cytokines such as IL-3, IL-5 and granulocyte macrophage-colony 
stimulating factor (GM-CSF) to the eosinophil. These cytokines promote 
chemoattractant-dependent eosinophil migration across the endothelial monolayer. 
Platelet activating factor (PAF) released by endothelial cells also promote eosinophil 
transmigration by increasing binding to ICAM-1 and decreasing expression of endothelial 
PSGL-1. Eosinophils also require the shearing forces of the flowing blood to maximize 
transmigration. Shear stress activates endothelial cells, which enhances their cytokine-
stimulated secretion of chemokines (32). With these conditions comes the requirement of 
the soluble/adhesion molecules already mentioned (21, 25, 26, 27, 32, 33). 
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Modifiers of Eosinophil Transmigration 
 Taking a step back, eosinophil recruitment by specific tissues is mediated by 
several chemokines such as eotaxin and RANTES as well as cytokines such as IL-4, IL-5, 
and TNF-α. The source of these chemokines ranges from leukocytes such as 
macrophages and Th2 cells to tissue cells such as adipocytes (16, 17, 25, 26, 27, 31, 33, 
34, 35). Eotaxin is the most potent chemoattractant signal for eosinophils and is involved 
in trafficking of eosinophils into specific tissues such as the mucosal tissues of the 
gastrointestinal tract and the peritoneal cavity (25, 26, 33, 34).  
 The chemokine eotaxin-1, also known as CCL11, is a member of the CC 
chemokine family (CC refers to adjacent cysteine residues: 12, 20, 21, 22, 56). Eotaxin is 
a non-glycosylated polypeptide secreted by epithelial cells, fibroblasts, macrophages and 
eosinophils (35). There are 2 additional isoforms of eotaxin [eotaxin-2 (CCL24) and 
eotaxin-3 (CCL26)] all of which are ligands for the chemokine receptor CCR3 located on 
eosinophils (16, 26, 27, 25, 32, 34).  
 Eotaxin-1, -2 or -3 can be secreted by epithelial cells, leukocytes and adipocytes 
(17, 35). Both differentiated adipocytes and pre-adipocytes secrete eotaxin, with the latter 
secreting more (35). In response to specific stimuli, adipocytes secrete high levels of 
eotaxin. For example, TNF-α elevates eotaxin secretion by 40-fold in 3T3-L1 pre-
adipocytes/adipocytes (35). Also, IL-4 and IL-5 secretion by eosinophils can increase 
eotaxin secretion by adipocytes as well, with IL-4 enhancing secretion greater than IL-5 
(35). Eotaxin secreted by other cells such as macrophages or eosinophils increase eotaxin 
secretion by adipocytes (35). Therefore, eosinophils could create a positive feedback loop 
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whereby eotaxin (or IL-4) secretion within adipose tissue would recruit more eosinophils 
and thereby promote the M2 macrophage (anti-inflammatory) response in lean 
individuals.  
 Another interesting aspect of eotaxin secretion by adipocytes is that it is impact 
by diet: a high fat diet elevates adipocytes eotaxin secretion. Switching to a low fat diet 
reduces eotaxin secretion as does maintaining a low fat diet (17, 35). This is consistent 
with the idea that TNF-α can elevate eotaxin secretion by adipocytes because obesity is 
an inflammatory state and TNF-α is an inflammatory cytokine.  
From the evidence presented above, the number of eosinophils within adipose 
tissue should be maintained or increased by elevating eotaxin.  However, eosinophil  
numbers have been reported to decrease under these conditions. It is possible that the 
obese state impedes the migration of eosinophils into the peritoneal cavity as well as 
other areas of adipose tissue. This could involve alterations in either endothelial cell or 
eosinophil that reduce transmigration. Interesting, eotaxins have been shown to alter the 
expression of endothelial cell gap junction proteins (connexins). These connexins play an 
important role in the regulation of endothelial cell function in the vasculature and may be 
involve in the eosinophil paradox (37, 38, 39, 40). 
 
Gap Junction Proteins 
 Connexins have received considerable interest for their ability to moderate 
inflammatory responses (38, 40). To form a gap junction between cells, 6 connexins 
associate into hemi-channels (connexon) that dock with a connexon on a neighboring 
cell. Once formed, these gap junctions gate to the open state allowing the diffusion of 
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electrical and chemical signals (< 1kDa) between cells (gap junctional intercellular 
communication: GJIC) (38-40).  Hemichannels are fluid in the plasma membrane moving 
laterally to dock with their counterparts in the neighboring cells to form gap junctions.  
 Because tissues depend on connexons for homeostasis and expression of the 22 
isoforms of the connexin protein is tissue specific, any dysregulation or mutation in a 
gene coding for a connexin can result in disease such as cataractogenesis, deafness, 
multiple skin disorders and heart disease (39). Relevant to the current study, the 
expression and/or the connectivity of connexins in tissues can be altered both in vitro and 
in vivo under inflammatory conditions such as obesity. Inflammatory mediators such as 
LPS and TNF-α can inhibit GJIC by phosphorylation of intracellular portions of 
connexons to alter the gating of the channel as well as its permeability (38, 39). 
Inflammation decreases the expression of endothelial cell Cx40, while increasing 
endothelial cell Cx37 expression.  Interestingly, Cx37 is also expressed by leukocytes. 
Thus, inflammation would alter the endothelial layer and could thereby contribute to its 
pathogenesis in the affected tissues (38, 39, 40).  
 In the current study, we are particularly interested in endothelial connexins that 
alter expression of adhesion molecules like VCAM-1 which would affect leukocyte 
adhesion in states of inflammation such as those induced by diet. Thus, Cx37, Cx40, and 
Cx43 are the focus of this study due to their role in inflammatory diseases such as 
atherosclerosis and asthma (37, 38, 39, 40).  
 Cx40 is expressed in endothelial cells of healthy individuals and some smooth 
muscle cells (SMCs). It prevents macrophage and leukocyte adhesion indirectly by 
preventing the surface expression of VCAM-1 (38, 39, 40). The coexpression of CD73 
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and Cx40 on the surface of endothelial cells down regulates VCAM-1 expression and 
thus decreases leukocyte or macrophage adhesion (mechanism will be discussed shortly). 
If Cx40 is absent or impaired due to inflammation, there will be increased VCAM-1 
expression and an increase in macrophages adhesion to the endothelial surface. Also, 
Cx40 is part of an anti-inflammatory signaling pathway within the pulmonary system that 
prevents the adhesion of neutrophils (38, 39, 40).  
 Like Cx40, Cx43 can also be expressed by both SMCs and endothelial cells. In 
terms of atherosclerosis, this connexin is considered “atherogenic” because its presence is 
related to increased macrophage infiltration within the vasculature, aiding in the 
progression of atherosclerotic plaque development. This connexin is also expressed on 
the surface of both macrophages and neutrophils, which could allow for intercellular 
communication between these cells respectively, as well as with other cell types (38, 39, 
40). Cx43 expression on SMCs and leukocytes can be up regulated in the presence of 
IFN-γ along with either LPS or TNF-α, thus showing its importance in the development 
of inflammatory diseases. Aside from atherosclerosis, Cx43 has been linked to a pro-
inflammatory state within the lungs involving the propagation of calcium waves between 
endothelial cells. These calcium waves promote the expression of P-selectin on the 
surface of the vasculature that facilitates leukocyte rolling on the vascular surface and 
thus leads to increased adhesion of leukocytes (mechanism promoting P-selectin 
expression is unknown) (38, 39, 40).  
 Cx37 is located on endothelial cells, some smooth muscle cells and macrophages 
and is protective against inflammatory diseases. Although this connexin plays an 
important role in both early and late atherosclerosis (38, 40), it also impacts macrophage 
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function. As shown in figure 5, Cx37 hemichannels on macrophages release ATP into the 
extracellular matrix. ATP is degraded by ectoenzymes CD39 and successively by CD73 
into AMP and then to nucleosides and inosine. In the anti-inflammatory state, CD73 
degrades AMP to adenosine (Ado), which binds to an A2BR receptor on the endothelial 
cells to reduce VCAM-1 expression to very low levels.  This would decrease the number 
of macrophages that cross the endothelial barrier. Simultaneously, Cx40 expression is 
enhanced within endothelial cells (40). Conversely, in a pro-inflammatory state CD73 is 
down-regulated on the endothelial surface due to a decrease in Cx40 expression and a 
increase in Cx43 expression caused by an inflammatory stimulus. In a parallel response, 
the Cx37 hemichannel is either blocked or expression on the macrophage is reduced to 
prevent the release of ATP into the extracellular environment. In the event that 
expression was reduced, small amounts of released ATP are able to bind to the purinergic 
receptor P2Y triggering Ca2+-dependent signaling that propagates between endothelial 
cells via Cx43 and increases the expression of endothelial leukocyte adhesion molecules 
(40). This allows for enhanced inflammatory cell adhesion and migration across the 
endothelial barrier in the tissue of interest (38, 40). 
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Figure 5: The effects of the anti-inflammatory and pro-inflammatory states on the 
expression of CD73 and Cx37 on endothelial cells and macrophages resulting in 
enhanced or reduced adhesion and thus migration across the endothelial barrier 
(38).  
 
 Based upon the data presented above, we will address the reason(s) underlying the 
decrease in eosinophil levels within obese individuals on a high fat diet that occurs 
despite elevated levels of eotaxin. Though the relationship between connexins and 
eosinophils remains largely unknown, Cx43 appear to influence eosinophil migration. 
Decreasing Cx43 expression within subepithelial fibroblasts in nasal polyps increased 
eosinophil infiltration (28).  Thus, the expression of Cx43 by eosinophils could be the key 
to understanding the regulation of eosinophil migration. Specifically, connexins on 
eosinophils or on the endothelial cells lining the blood vessels of the peritoneal cavity 
may reduce eosinophil population in adipose tissue by altering proteins responsible for 
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endothelial-leukocyte adhesion. Therefore, this proposal will investigate the impact of 
free SFA on connexin expression in eosinophils and endothelial cells. If a cellular 
environment high in saturated fat can alter the expression of connexins on either cell type 
then this could explain the reduction in eosinophil migration.  
 
Endothelial Cells and PRRs 
 Endothelial cells are unique in that they are one of the most abundant cells in the 
body and together they form the largest interconnected organ in the human body (41). 
Their abundance and function as a barrier to all body cavities and blood vessels render 
them an important part of the body’s defense system, more specifically the innate 
immune system. Endothelial cells contain many surface receptors such as pattern 
recognition receptors (PRR) and adhesion molecules such as selectins (41). These surface 
molecules allow the endothelial layer to react to specific soluble stimuli such as LPS, 
chemokines, and cytokines and respond with regulation of leukocyte migration from the 
blood stream into various tissues (41, 42, 43).  
 Of the surface molecules expressed on endothelial cells, TLR-4 appears to be 
most important in the innate immune response. As mentioned before, TLR-4 is a pattern 
recognition receptor that is located on many cells from leukocytes like macrophages and 
eosinophils to non-bone marrow-derived parenchymal cells like endothelial cells (41, 42, 
43). Expression of TLR-4 on the endothelial cells makes them susceptible to activation 
by LPS and the subsequent alterations in adhesion molecules expression as well as 
cytokines and chemokines secretion.  
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 Similar to the monocytes, the interaction between LPS and TLR-4 on the surface 
of endothelial cells results in the activation of the transcription factor NF- kB by MyD88, 
IL-1 receptor-associated kinase (IRAK), IRAK-2 and TNF receptor-associated factor-6 
(42, 43). Activated endothelial cells secrete inflammatory cytokines and chemokines and 
subsequent alteration of selectin and integrin expression. However, unlike the monocyte 
endothelial cell activation is dependent upon the soluble CD14 rather than a membrane 
bound CD14 (42).  
 Upon the activation of the endothelial cell by TLR-4, the cell will begin to change 
expression of adhesion molecules to favor leukocyte rolling and transmigration across the 
endothelial barrier and into tissues. This occurs through an increase in P-selectin 
expression to tether cells like neutrophils, eosinophils and macrophages, allowing them to 
tightly bind to the endothelium and initiating the process that ultimately leads to 
transmigration. This is important in the rapid clearance of a bacterial infection (41). TLR-
4 activation can also alter endothelial connexin expression which could affect expression 
of surface adhesion molecule (i.e. Cx43 could increase  P-selectin expression: 39, 40). 
 Along with expression of PRRs such as TLR-4, endothelial cells also express 
PPARγ that is activated by UFAs  (43). Similar to macrophages, the activation of this 
subunit on endothelial cells dampens the inflammatory response by interfering with NF-
kB activation. Therefore, PPARγ activation by UFA would resolve an inflammation 
response (43). 
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Endothelial Cell Response to Fatty Acids and Connexin Expression 
 Endothelial cells expression of TLR-4 and PPARγ receptors allows them to 
interact with both saturated and polyunsaturated fatty acids. This means that fats impact 
not only their internal function, in terms of cell stress, but also their expression of surface 
molecules and regulation of cell migration and innate immune function.  
For example, SFA such as palmitic acid (C16:0) and lauric acid (C12:0) act through 
TLR-4 on endothelial cells to induce translocation of Cx43 to the mitochondria 
membrane which can depress mitochondrial membrane potential in cells (marker of 
endothelial cell stress and dysfunction. It alters membrane potential by acting as a 
channel, similar to a potassium channel regulated by ATP, which is thought to have 
cytoprotective effects on the cell by enhancing the mitochondrial function within the cell 
(9).  
Mitochondrial membrane potential and that membranes permeability maintains 
the function of the electron transport chain. When a cell is undergoing the ER stress 
response, hypoxia or is being stimulated by LPS or TNF-α, the mitochondrial membrane 
potential decreases due to substrates like free FA or toxic free radicals. These substrates 
cause a dysfunction in the respiratory chain thereby increasing the reactive oxidative 
species (ROS) that can lead to cell death through apoptotic or necrotic mechanisms.  
Therefore, the ideal situation would be to increase mitochondrial membrane potential and 
decrease Cx43 expression within the mitochondria. UFAs like arachidonic acid (AA; n-6 
UFA) and eicosapentanoic acid (EPA; n-3 UFA) or their precursors (linoleic and α-
linolenic acids respectively) act through PPARγ to elevate inner mitochondrial membrane 
potential in endothelial cells to combat cell stress, prevent apoptosis and in some cases 
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increase Cx43 translocation to the mitochondrial membrane (9). Therefore, these UFAs 
or their precursors appear as ideal targets for combating the effects associated with an 
inflammatory environment (i.e. cell death, inflammatory cell migration, etc.) (9, 44, 45). 
 
Poly-Unsaturated Fatty Acids: Omega-3 vs. Omega-6 
With UFAs becoming the center of focus to combat problems associated with 
diet-induced obesity, research has led to the grouping of UFAs into beneficial and non-
beneficial. EPA, or its precursor α-linolenic acid, is an omega-3 fatty acids derived from 
fish oils that is the most beneficial of the UFAs. This source of fatty acid has been shown 
to not only be anti-inflammatory, but also decreases monocyte adhesion and reverses 
insulin resistance. Alternatively, AA and linoleic acid, are omega-6 fatty acids that 
stimulate inflammation. In fact, they are one of the breakdown products of apoptotic 
adipocytes present in diet-induced obese individuals that contributes to the inflammatory 
environment associated with medical complications (9, 44, 45).  
Arachidonic Acid increases monocyte adhesion to endothelial cells regardless of 
endothelial cell activation due to inflammatory cytokines. This occurs through the 
increased endothelial expression of integrins and selectins like ICAM-1, VCAM-1 and E-
selectin (44). However, the effect of AA on connexin expression in endothelial cells 
remains questionable, as it has also been shown to have similar results as EPA. This 
could be due to the fact that both UFAs act through PPARγ and down regulate 
inflammatory transcription factors (9, 44, 45, 46). Regardless of previous research, more 
research must be done to determine the exact benefits and differences between the two 
fatty acids until a viable explanation is reached. 
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 IV. Conclusion  
The fact that endothelial cells express both TLR-4 and PPARγ receptors opens a 
realm of possibilities when questioning the impact of SFA and UFA on migration of 
eosinophils across the endothelial barrier. Specifically, it gives two possibilities in 
regards to why there is a lack of eosinophils migrating into the peritoneal cavity in diet-
induced obese individuals; there is a change in endothelial cells or in the eosinophil. As 
mentioned before with the eosinophil, the three subcategory problems were as follows: 1) 
Eosinophils can transmigrate but die in the tissue due to the cellular environment, 2) 
eosinophils migrate to the cavity but are unable to cross the endothelial barrier, or 3) the 
eosinophils are transmigrating into the tissue but have shifted to secretion of pro-
inflammatory cytokines and thus contribute to the problem. 
 On the other hand, endothelial cells could be the root of the problem for why 
eosinophils are not transmigrating into the affected tissue, resulting in the unfavorable 
polarization to M1 macrophages within the specific tissue. Focusing on endothelial cells 
and incorporating the idea of connexin expression then the problem could be simple, 
which is that SFAs are binding to TLR-4 receptors on the endothelial cells resulting in 
increased expression of adhesion molecules that facilitate eosinophil migration into 
adipose tissues. If eosinophils were entering the tissue in this state of inflammation then it 
would be possible that they are compromising their secretion of cytokines IL-4 and IL-13 
and instead secreting pro-inflammatory cytokines that could amplify the M1 response 
leading to insulin resistance.  
 52 
 If SFAs such as palmitic acid or lauric acid are the root of the problem then the 
answer could be as simple as naturally consuming, taking supplemental or injected forms 
of Poly unsaturated fatty acids such as alpha-linolenic acid, an Omega-3 fatty acid, or 
linoleic acid, an Omega-6 fatty acid (9, 44, 45). This would increase expression of cardio-
protective connexins such as Connexin40 and Cx37, while decreasing CX43 expression 
to dampen inflammatory cell migration and maintaining the appropriate balance of M2 to 
M1 macrophages and eosinophils within the adipose tissue to prevent insulin resistance.  
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